Up
2006P-0462:
Determine whether Prevacid NapraPAC, 15 mg/250 mg (lansoprazole
delayed-release, 15 mg capsules and naproxen 250 mg tablets kit)
(NDA No. 021507) by Tap Pharm, has been Voluntarily Withdrawn or
Withheld from Sale for Safety or Efficacy Reasons
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| CP1
|
| 11/13/2006
|
| 11/13/2006
|
| Private Industry
|
| Lachman Consultant
Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Robert W. Pollock
|
|
|
| ACK1
|
| 11/13/2006
|
| 11/13/2006
|
| Federal Government
|
| FDA/DDM to Lachman
Consultant Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
Top | Up
Page last updated
November 21, 2006
kk![horizonal rule](https://webarchive.library.unt.edu/eot2008/20081024203749im_/http://www.fda.gov/graphics/blkpixel.gif)
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |